These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
326 related items for PubMed ID: 12611586
1. Carbonic anhydrase-related protein is a novel binding protein for inositol 1,4,5-trisphosphate receptor type 1. Hirota J, Ando H, Hamada K, Mikoshiba K. Biochem J; 2003 Jun 01; 372(Pt 2):435-41. PubMed ID: 12611586 [Abstract] [Full Text] [Related]
2. Differential modulation of inositol 1,4,5-trisphosphate receptor type 1 and type 3 by ATP. Maes K, Missiaen L, De Smet P, Vanlingen S, Callewaert G, Parys JB, De Smedt H. Cell Calcium; 2000 May 01; 27(5):257-67. PubMed ID: 10859592 [Abstract] [Full Text] [Related]
3. The regulatory domain of the inositol 1,4,5-trisphosphate receptor is necessary to keep the channel domain closed: possible physiological significance of specific cleavage by caspase 3. Nakayama T, Hattori M, Uchida K, Nakamura T, Tateishi Y, Bannai H, Iwai M, Michikawa T, Inoue T, Mikoshiba K. Biochem J; 2004 Jan 15; 377(Pt 2):299-307. PubMed ID: 12968951 [Abstract] [Full Text] [Related]
4. The suppressor domain of inositol 1,4,5-trisphosphate receptor plays an essential role in the protection against apoptosis. Szlufcik K, Bultynck G, Callewaert G, Missiaen L, Parys JB, De Smedt H. Cell Calcium; 2006 Apr 15; 39(4):325-36. PubMed ID: 16458354 [Abstract] [Full Text] [Related]
5. Ca2+ and calmodulin differentially modulate myo-inositol 1,4, 5-trisphosphate (IP3)-binding to the recombinant ligand-binding domains of the various IP3 receptor isoforms. Vanlingen S, Sipma H, De Smet P, Callewaert G, Missiaen L, De Smedt H, Parys JB. Biochem J; 2000 Mar 01; 346 Pt 2(Pt 2):275-80. PubMed ID: 10677344 [Abstract] [Full Text] [Related]
9. 4.1N binding regions of inositol 1,4,5-trisphosphate receptor type 1. Fukatsu K, Bannai H, Inoue T, Mikoshiba K. Biochem Biophys Res Commun; 2006 Apr 07; 342(2):573-6. PubMed ID: 16487933 [Abstract] [Full Text] [Related]
10. The N-terminal Ca2+-independent calmodulin-binding site on the inositol 1,4,5-trisphosphate receptor is responsible for calmodulin inhibition, even though this inhibition requires Ca2+. Kasri NN, Bultynck G, Smyth J, Szlufcik K, Parys JB, Callewaert G, Missiaen L, Fissore RA, Mikoshiba K, de Smedt H. Mol Pharmacol; 2004 Aug 07; 66(2):276-84. PubMed ID: 15266018 [Abstract] [Full Text] [Related]
11. Nuclear inositol 1,4,5-trisphosphate receptors regulate local Ca2+ transients and modulate cAMP response element binding protein phosphorylation. Cárdenas C, Liberona JL, Molgó J, Colasante C, Mignery GA, Jaimovich E. J Cell Sci; 2005 Jul 15; 118(Pt 14):3131-40. PubMed ID: 16014380 [Abstract] [Full Text] [Related]
12. Inositol 1,4,5-trisphosphate receptor type 1 phosphorylation and regulation by extracellular signal-regulated kinase. Bai GR, Yang LH, Huang XY, Sun FZ. Biochem Biophys Res Commun; 2006 Oct 06; 348(4):1319-27. PubMed ID: 16925983 [Abstract] [Full Text] [Related]
19. Subtype-specific and ER lumenal environment-dependent regulation of inositol 1,4,5-trisphosphate receptor type 1 by ERp44. Higo T, Hattori M, Nakamura T, Natsume T, Michikawa T, Mikoshiba K. Cell; 2005 Jan 14; 120(1):85-98. PubMed ID: 15652484 [Abstract] [Full Text] [Related]
20. Ataxia and epileptic seizures in mice lacking type 1 inositol 1,4,5-trisphosphate receptor. Matsumoto M, Nakagawa T, Inoue T, Nagata E, Tanaka K, Takano H, Minowa O, Kuno J, Sakakibara S, Yamada M, Yoneshima H, Miyawaki A, Fukuuchi Y, Furuichi T, Okano H, Mikoshiba K, Noda T. Nature; 1996 Jan 11; 379(6561):168-71. PubMed ID: 8538767 [Abstract] [Full Text] [Related] Page: [Next] [New Search]